KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Cash from Investing Activities (2016 - 2025)

Omega Healthcare Investors' Cash from Investing Activities history spans 14 years, with the latest figure at -$11.7 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 95.84% year-over-year to -$11.7 million; the TTM value through Dec 2025 reached -$539.8 million, up 19.57%, while the annual FY2025 figure was -$539.8 million, 19.57% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$11.7 million at Omega Healthcare Investors, up from -$83.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $177.3 million in Q1 2022 and bottomed at -$463.5 million in Q2 2025.
  • The 5-year median for Cash from Investing Activities is -$29.6 million (2024), against an average of -$64.7 million.
  • The largest annual shift saw Cash from Investing Activities skyrocketed 1629.5% in 2023 before it crashed 1886.0% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$72.0 million in 2021, then soared by 336.64% to $170.4 million in 2022, then plummeted by 34.68% to $111.3 million in 2023, then plummeted by 353.08% to -$281.7 million in 2024, then soared by 95.84% to -$11.7 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Cash from Investing Activities are -$11.7 million (Q4 2025), -$83.8 million (Q3 2025), and -$463.5 million (Q2 2025).